KalVista Pharmaceuticals (KALV) Total Non-Current Liabilities: 2014-2024
Historic Total Non-Current Liabilities for KalVista Pharmaceuticals (KALV) over the last 4 years, with Dec 2024 value amounting to $30.6 million.
- KalVista Pharmaceuticals' Total Non-Current Liabilities was N/A to $30.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $30.6 million, marking a year-over-year change of. This contributed to the annual value of $6.0 million for FY2024, which is N/A change from last year.
- KalVista Pharmaceuticals' Total Non-Current Liabilities amounted to $30.6 million in Q4 2024, which was up 553.50% from $4.7 million recorded in Q4 2024.
- KalVista Pharmaceuticals' 5-year Total Non-Current Liabilities high stood at $30.6 million for Q4 2024, and its period low was $932,000 during Q4 2020.
- In the last 2 years, KalVista Pharmaceuticals' Total Non-Current Liabilities had a median value of $6.3 million in 2024 and averaged $9.4 million.
- Data for KalVista Pharmaceuticals' Total Non-Current Liabilities shows a maximum YoY plummeted of 75.52% (in 2020) over the last 5 years.
- KalVista Pharmaceuticals' Total Non-Current Liabilities (Quarterly) stood at $932,000 in 2020, then tumbled by 67.22% to $1.1 million in 2021, then reached $6.5 million in 2023, then decreased by 28.58% to $30.6 million in 2024.
- Its Total Non-Current Liabilities was $30.6 million in Q4 2024, compared to $4.7 million in Q4 2024 and $5.0 million in Q3 2024.